K. Ogata

Safety and activity of trifluridine/tipiracil and ramucirumab in previously treated advanced gastric cancer: an open-label, single-arm, phase 2 trial.

T. Ando, Yuji Yamamoto, K. Amagai, 2021, The lancet. Gastroenterology & hepatology.

Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy

M. Murayama, T. Sambe, Y. Hirasawa, 2022, Frontiers in Pharmacology.

Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial

Y. Kodera, Masato Nakamura, H. Ohdan, 2020, Gastric Cancer.

Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial

Y. Kodera, Masato Nakamura, H. Ohdan, 2020, Gastric Cancer.

Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial

Y. Kodera, Masato Nakamura, H. Ohdan, 2020, Gastric Cancer.